American International Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-45,658
| Closed | -$110K | – | 1545 |
|
|
2024
Q1 | $110K | Sell |
45,658
-391
| -0.8% | -$840 | ﹤0.01% | 2463 |
|
|
2023
Q4 | $70.5K | Sell |
46,049
-186
| -0.4% | -$221 | ﹤0.01% | 2723 |
|
|
2023
Q3 | $50.4K | Buy |
46,235
+1,644
| +4% | +$2.88K | ﹤0.01% | 2814 |
|
|
2023
Q2 | $102K | Buy |
44,591
+4,398
| +11% | +$11.7K | ﹤0.01% | 2563 |
|
|
2023
Q1 | $97.7K | Buy |
40,193
+800
| +2% | +$1.83K | ﹤0.01% | 2465 |
|
|
2022
Q4 | $75.2K | Sell |
39,393
-143
| -0.4% | -$304 | ﹤0.01% | 2628 |
|
|
2022
Q3 | $95K | Buy |
39,536
+5,444
| +16% | +$15.1K | ﹤0.01% | 2586 |
|
|
2022
Q2 | $63K | Sell |
34,092
-665
| -2% | -$1.27K | ﹤0.01% | 2795 |
|
|
2022
Q1 | $73K | Sell |
34,757
-2,445
| -7% | -$6.78K | ﹤0.01% | 2714 |
|
|
2021
Q4 | $147K | Buy |
37,202
+47
| +0.1% | +$228 | ﹤0.01% | 2539 |
|
|
2021
Q3 | $179K | Sell |
37,155
-883
| -2% | -$3.62K | ﹤0.01% | 2492 |
|
|
2021
Q2 | $175 | Buy |
38,038
+9,054
| +31% | +$43.6K | ﹤0.01% | 2597 |
|
|
2021
Q1 | $170 | Buy |
28,984
+4,984
| +21% | +$34.5K | ﹤0.01% | 2449 |
|
|
2020
Q4 | $82 | Sell |
24,000
-688
| -3% | -$1.31K | ﹤0.01% | 2750 |
|
|
2020
Q3 | $36K | Sell |
24,688
-562
| -2% | -$1K | ﹤0.01% | 2973 |
|
|
2020
Q2 | $50K | Buy |
25,250
+681
| +3% | +$1.33K | ﹤0.01% | 2881 |
|
|
2020
Q1 | $48K | Sell |
24,569
-1,419
| -5% | -$4.22K | ﹤0.01% | 2698 |
|
|
2019
Q4 | $108K | Sell |
25,988
-220
| -0.8% | -$847 | ﹤0.01% | 2580 |
|
|
2019
Q3 | $79K | Sell |
26,208
-182
| -0.7% | -$563 | ﹤0.01% | 2726 |
|
|
2019
Q2 | $166K | Sell |
26,390
-1,166
| -4% | -$6.98K | ﹤0.01% | 2358 |
|
|
2019
Q1 | $153K | Sell |
27,556
-893
| -3% | -$5.42K | ﹤0.01% | 2358 |
|
|
2018
Q4 | $189K | Sell |
28,449
-220
| -0.8% | -$1.78K | ﹤0.01% | 2214 |
|
|
2018
Q3 | $306K | Buy |
28,669
+518
| +2% | +$5.94K | ﹤0.01% | 2160 |
|
|
2018
Q2 | $338K | Buy |
28,151
+605
| +2% | +$6.19K | ﹤0.01% | 2065 |
|
|
2018
Q1 | $236K | Sell |
27,546
-1,482
| -5% | -$13.7K | ﹤0.01% | 2169 |
|
|
2017
Q4 | $287K | Buy |
29,028
+137
| +0.5% | +$1.42K | ﹤0.01% | 2100 |
|
|
2017
Q3 | $355K | Buy |
28,891
+2,161
| +8% | +$31.9K | ﹤0.01% | 1956 |
|
|
2017
Q2 | $440K | Buy |
26,730
+710
| +3% | +$11K | ﹤0.01% | 1792 |
|
|
2017
Q1 | $373K | Buy |
26,020
+1,716
| +7% | +$25.5K | ﹤0.01% | 1804 |
|
|
2016
Q4 | $336K | Sell |
24,304
-64
| -0.3% | -$1.03K | ﹤0.01% | 1884 |
|
|
2016
Q3 | $440K | Buy |
24,368
+37
| +0.2% | +$595 | ﹤0.01% | 1688 |
|
|
2016
Q2 | $349K | Sell |
24,331
-450
| -2% | -$6.1K | ﹤0.01% | 1784 |
|
|
2016
Q1 | $296K | Hold |
24,781
| – | – | ﹤0.01% | 2424 |
|
|
2015
Q4 | $330K | Buy |
24,781
+123
| +0.5% | +$1.51K | ﹤0.01% | 2363 |
|
|
2015
Q3 | $265K | Buy |
24,658
+29
| +0.1% | +$317 | ﹤0.01% | 2569 |
|
|
2015
Q2 | $198K | Buy |
24,629
+3,770
| +18% | +$27.7K | ﹤0.01% | 3019 |
|
|
2015
Q1 | $138K | Hold |
20,859
| – | – | ﹤0.01% | 3298 |
|
|
2014
Q4 | $133K | Sell |
20,859
-767
| -4% | -$6.18K | ﹤0.01% | 3323 |
|
|
2014
Q3 | $213K | Sell |
21,626
-16
| -0.1% | -$171 | ﹤0.01% | 2904 |
|
|
2014
Q2 | $244K | Sell |
21,642
-726
| -3% | -$7.8K | ﹤0.01% | 2812 |
|
|
2014
Q1 | $271K | Buy |
22,368
+531
| +2% | +$6.79K | ﹤0.01% | 2579 |
|
|
2013
Q4 | $275K | Sell |
21,837
-217
| -1% | -$3.45K | ﹤0.01% | 2495 |
|
|
2013
Q3 | $366K | Buy |
22,054
+963
| +5% | +$16.2K | ﹤0.01% | 2216 |
|
|
2013
Q2 | $320K | Buy |
+21,091
| New | +$320K | ﹤0.01% | 2179 |
|
Other funds holding LXRX
AG
B
O
NMC